NBDC Research ID: hum0464.v1

 

SUMMARY

Aims: Radical treatments for hematopoietic tumors such as leukemia, myelodysplastic syndromes, myeloproliferative tumors, and multiple myeloma have not been fully established. One of the major factors hindering the efforts to find such treatments is the difficulty in constructing model mice that appropriately mimic the disease state. In this study, we collected peripheral blood or bone marrow cells from patients with hematological tumors and attempted in vitro cultures and molecular cell biological analyses, including genetic and epigenetic studies. Based on the knowledge gained from these studies, we aim to create patient-derived xenograft mouse models of hematological tumors and further develop new therapeutic approaches.

Methods: A part of bone marrow aspirates obtained to establish a definite diagnosis or evaluate the disease status was provided for this study. Mononuclear cells were separated by gradient separation using Ficoll, and then subjected to magnetic beads separation or FACS sorting to purify tumor cells. Next, they were subjected to RNA sequencing to analyze gene expression profiles.

Participants/Materials:

      [RNA-seq] A total of 86 bone marrow samples from 17 multiple myelomas

      [single-cell RNA-seq, scBCR-seq] A total of 22 bone marrow samples from 9 multiple myelomas

 

Dataset IDType of DataCriteriaRelease Date
JGAS000723 NGS (RNA-seq, scRNA-seq, scBCR-seq) Controlled-access (Type I) 2024/07/25

*Release Note

*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

 

RNA-seq

Participants/Materials

multiple myeloma (ICD10: C90.0): 17 cases

      bone marrow: 86 samples

            11 fractions: 8 cases (60 samples)

            CD138 positive/negative cell pairs: 13 cases (26 samples)

Targets RNA-seq
Target Loci for Capture Methods -
Platform Illumina [HiSeq 2000, NextSeq 2000]
Library Source RNAs extracted from 11 fractions of cells or CD138+/- cells
Cell Lines -
Library Construction (kit name) SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing, SMART-Seq HT Kit, NEBNext Ultra DNA Library Prep Kit for Illumina
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 70 bp
Japanese Genotype-phenotype Archive Dataset ID JGAD000856
Total Data Volume 143.0 GB(fastq)
Comments (Policies) NBDC policy

 

scRNA-seq, scBCR-seq

Participants/Materials

multiple myeloma (ICD10: C90.0): 9 cases

      bone marrow: 22 samples

      (scRNA-seq: 11 samples, scBCR-seq: 11 samples)

Targets scRNA-seq, scBCR-seq
Target Loci for Capture Methods -
Platform Illumina [HiSeq 2000]
Library Source RNAs extracted from CD38+ cells
Cell Lines -
Library Construction (kit name) Chromium Next GEM Single Cell 5' Kit v2, Chromium Single Cell Human BCR Amplification Kit
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 90 bp
Japanese Genotype-phenotype Archive Dataset ID JGAD000856
Total Data Volume 143.0 GB(fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Atsushi Iwama

Affiliation: Division of Stem Cell and Molecular Medicine Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, University of Tokyo

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
KAKENHI Grant-in-Aid for Scientific Research (S) Pathogenec implication of hematopoietic stem cell aging in age-associated hematological malignancies JP24H00066

 

PUBLICATIONS

TitleDOIDataset ID
1

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use